Decreased density of tyrosine hydroxylase–immunoreactive axons in the entorhinal cortex of schizophrenic subjects

[1]  S. Sesack,et al.  Dopamine innervation of monkey entorhinal cortex: Postsynaptic targets of tyrosine hydroxylase‐immunoreactive terminals , 2000, Synapse.

[2]  Mary Tolcos,et al.  Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia , 1999, Schizophrenia Research.

[3]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[4]  J. Finlay,et al.  Effects of partial dopamine loss in the medial prefrontal cortex on local baseline and stress-evoked extracellular dopamine concentrations , 1999, Neuroscience.

[5]  R. Conley,et al.  Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study , 1998, Molecular Psychiatry.

[6]  A. Levey,et al.  Postnatal development of tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. , 1998, Cerebral cortex.

[7]  N. Alpert,et al.  Impaired recruitment of the hippocampus during conscious recollection in schizophrenia , 1998, Nature Neuroscience.

[8]  K. Davis,et al.  Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. , 1997, Archives of general psychiatry.

[9]  L. Glantz,et al.  Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.

[10]  M. Akil,et al.  Cytoarchitecture of the entorhinal cortex in schizophrenia. , 1997, The American journal of psychiatry.

[11]  M. Akil,et al.  Cortical dopamine in schizophrenia: strategies for postmortem studies. , 1997, Journal of psychiatric research.

[12]  J. Hietala,et al.  Dopamine in schizophrenia. , 1996, Annals of medicine.

[13]  G. V. Van Hoesen,et al.  Entorhinal cortex modules of the human brain , 1996, The Journal of comparative neurology.

[14]  S. Sesack,et al.  Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA‐immunoreactive dendrites in rat and monkey cortex , 1995, The Journal of comparative neurology.

[15]  D. Rosenberg,et al.  Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis , 1995, The Journal of comparative neurology.

[16]  J. Trojanowski,et al.  Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. , 1995, The American journal of psychiatry.

[17]  R. Insausti,et al.  The human entorhinal cortex: A cytoarchitectonic analysis , 1995, The Journal of comparative neurology.

[18]  M. Akil,et al.  The distribution of tyrosine hydroxylase-immunoreactive fibers in the human entorhinal cortex , 1994, Neuroscience.

[19]  M. Akil,et al.  The dopaminergic innervation of monkey entorhinal cortex. , 1993, Cerebral cortex.

[20]  M. Witter Organization of the entorhinal—hippocampal system: A review of current anatomical data , 1993, Hippocampus.

[21]  Robin M. Murray,et al.  Schizophrenia: A Neurodevelopmental Perspective , 1993, Neuropsychopharmacology.

[22]  J. Haycock,et al.  Four isoforms of tyrosine hydroxylase are expressed in human brain , 1993, Neuroscience.

[23]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[24]  H. Braak,et al.  The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases , 1992, Neuroscience Research.

[25]  D. Lewis,et al.  Heterogeneity of layer II neurons in human entorhinal cortex , 1992, The Journal of comparative neurology.

[26]  A. Deutch,et al.  Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[28]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[29]  Douglas W. Jones,et al.  The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  D. Melchitzky,et al.  Neuronal localization of tyrosine hydroxylase gene products in human neocortex , 1991, Molecular and Cellular Neuroscience.

[31]  D. Amaral,et al.  Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex , 1991, The Journal of comparative neurology.

[32]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[33]  A. Young,et al.  A Magnetic Resonance Imaging Study of Schizophrenia: Brain Structure and Clinical Symptoms , 1991, British Journal of Psychiatry.

[34]  T. Goldberg,et al.  The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. , 1990, Archives of general psychiatry.

[35]  M. Witter,et al.  Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region , 1989, Progress in Neurobiology.

[36]  D. Amaral,et al.  Topographical organization of the entorhinal projection to the dentate gyrus of the monkey , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  B. Bogerts,et al.  Limbic pathology in schizophrenia: The entorhinal region—a morphometric study , 1988, Biological Psychiatry.

[38]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.

[39]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.

[40]  D. Amaral,et al.  The entorhinal cortex of the monkey: II. Cortical afferents , 1987, The Journal of comparative neurology.

[41]  D. Amaral,et al.  The entorhinal cortex of the monkey: I. Cytoarchitectonic organization , 1987, The Journal of comparative neurology.

[42]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[43]  M J Campbell,et al.  An immunohistochemical characterization of somatostatin‐28 and somatostatin‐281–12 in monkey prefrontal cortex , 1986, The Journal of comparative neurology.

[44]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[45]  B. Bogerts,et al.  Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage , 1985 .

[46]  J. Haycock,et al.  The localization of tyrosine hydroxylase-like immunoreactivity in the central nervous system: Methodological considerations , 1984, Brain Research Bulletin.

[47]  G. V. Hoesen,et al.  The parahippocampal gyrus: New observations regarding its cortical connections in the monkey , 1982, Trends in Neurosciences.

[48]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[49]  T. Jeffcoate DISORDERS OF MENSTRUATION , 1957 .

[50]  Paul J. Harrison The neuropathology of schizophrenia , 2008 .

[51]  R. Kerwin,et al.  Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. , 1998, Brain research. Molecular brain research.

[52]  S. Sesack,et al.  Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.

[53]  R. Saunders,et al.  A Qualitative and Quantitative Analysis of the Entorhinal Cortex in Schizophrenia , 1997 .

[54]  S. Sesack,et al.  Chapter VI Dopamine systems in the primate brain , 1997 .

[55]  S. Arnold The medial temporal lobe in schizophrenia. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[56]  A. Heritch,et al.  Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. , 1990, Schizophrenia bulletin.

[57]  D. Weinberger,et al.  The effect of apomorphine on regional cerebral blood flow in schizophrenia. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[58]  L. DeLisi,et al.  Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. , 1988, Schizophrenia bulletin.